日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center

移植后,Guadecitabine 改善了高危急性髓系白血病和骨髓增生异常综合征患者的无复发生存期:单中心 II 期临床试验结果

Oran, Betül; Thall, Peter; Alousi, Amin; Al-Atrash, Gheath; Mehta, Rohtesh; Marin, David; Kebriaei, Partow; Popat, Uday; Bassett, Roland; Bashir, Qaiser; Im, Jin; Olson, Amanda; Jewell, Jessica; Smallbone, Portia; Shpall, Elizabeth; Champlin, Richard

BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing Changes

BAR12:贝叶斯自回归1-2期细胞治疗试验设计(考虑生产变更)

Yang, Cheng-Han; Thall, Peter F; Marin, David; Belay, Sheferaw Y; Lin, Ruitao

Practical Bayesian Guidelines for Small Randomized Oncology Trials

小型随机肿瘤试验的实用贝叶斯指南

Thall, Peter F

Cognitive tasks show age-related decline over a 10-year period in a natural aging monkey model, cotton-top tamarins (Saguinus oedipus)

在自然衰老的猴子模型——棉顶狨猴(Saguinus oedipus)中,认知任务显示出与年龄相关的衰退,这种衰退持续了 10 年。

Neiworth, Julie J; Gillespie, Scott P; Kwon, Ye In Christopher; Rieth, Isabelle; Thall, Madeline; Sharer, Abigail; Groesbeck, Elizabeth; Henderson, Lydia; Min, Chae Sarah; Tachida, Ayumi; Ma, Xiao; Rogers, Ella; Cablk, Megan; Raicevic, Anka; LoRusso, Madeline; Wang, Emerald

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

异基因CD19特异性CAR-NK细胞治疗CD19+ B细胞肿瘤的安全性、有效性和疗效决定因素:一项1/2期试验

David Marin # ,Ye Li # ,Rafet Basar # ,Hind Rafei # ,May Daher # ,Jinzhuang Dou ,Vakul Mohanty ,Merve Dede ,Yago Nieto ,Nadima Uprety ,Sunil Acharya ,Enli Liu ,Jeffrey Wilson ,Pinaki Banerjee ,Homer A Macapinlac ,Christina Ganesh ,Peter F Thall ,Roland Bassett ,Mariam Ammari ,Sheetal Rao ,Kai Cao ,Mayra Shanley ,Mecit Kaplan ,Chitra Hosing ,Partow Kebriaei ,Loretta J Nastoupil ,Christopher R Flowers ,Sadie Mae Moseley ,Paul Lin ,Sonny Ang ,Uday R Popat ,Muzaffar H Qazilbash ,Richard E Champlin ,Ken Chen ,Elizabeth J Shpall ,Katayoun Rezvani

High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas

吉西他滨/氯法拉滨/白消安新型清髓方案在异基因移植治疗侵袭性淋巴瘤中具有高活性

Ramdial, Jeremy; Lin, Ruitao; Thall, Peter F; Valdez, Benigno C; Hosing, Chitra; Srour, Samer; Popat, Uday; Qazilbash, Muzaffar; Alousi, Amin; Barnett, Melissa; Gulbis, Alison; Shigle, Terri Lynn; Shpall, Elizabeth J; Andersson, Borje S; Nieto, Yago

Intraoperative methadone administration for total mastectomy: A single center retrospective study

全乳切除术中应用美沙酮:一项单中心回顾性研究

Cata, Juan P; Zaidi, Yusuf; Guerra-Londono, Juan Jose; Kharasch, Evan D; Piotrowski, Matthew; Kee, Spencer; Cortes-Mejia, Nicolas A; Gloria-Escobar, Jose Miguel; Thall, Peter F; Lin, Ruitao

Whole-body galactose oxidation as a robust functional assay to assess the efficacy of gene-based therapies in a mouse model of Galactosemia

全身半乳糖氧化作为一种可靠的功能性检测方法,可用于评估基因疗法在半乳糖血症小鼠模型中的疗效。

Balakrishnan, Bijina; Yan, Xinhua; McCue, Marshall D; Bellagamba, Olivia; Guo, Aaron; Winkler, Felicity; Thall, Jason; Crawford, Lisa; Dimen, Rain; Chen, Sara; McEnaney, Sean; Wu, Yiman; Zimmer, Mike; Sarkis, Joe; Martini, Paolo G V; Finn, Patrick F; Lai, Kent

Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma

体外扩增脐带血自然杀伤细胞联合利妥昔单抗、大剂量化疗及自体干细胞移植治疗B细胞非霍奇金淋巴瘤

Nieto, Yago; Banerjee, Pinaki; Kaur, Indresh; Kim, Kun Hee; Fang, Dexing; Thall, Peter F; Griffin, Lori; Barnett, Melissa; Basar, Rafet; Hosing, Chitra; Ramdial, Jeremy; Srour, Samer; Daher, May; Marin, David; Jiang, Xianli; Chen, Ken; Champlin, Richard; Shpall, Elizabeth J; Rezvani, Katayoun

Risk-benefit trade-offs and precision utilities in phase I-II clinical trials

I-II期临床试验中的风险收益权衡和精确效用

Msaouel, Pavlos; Lee, Juhee; Thall, Peter F